Knopman D - Search Results

1

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW Jr, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. Clark CM, et al. Among authors: knopman d. Arch Neurol. 2003 Dec;60(12):1696-702. doi: 10.1001/archneur.60.12.1696. Arch Neurol. 2003. PMID: 14676043

2

An update on primary drug therapies for Alzheimer disease.

Knopman DS, Morris JC. Knopman DS, et al. Arch Neurol. 1997 Nov;54(11):1406-9. doi: 10.1001/archneur.1997.00550230073020. Arch Neurol. 1997. PMID: 9362990 Review.

3

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Among authors: knopman d. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

4

Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study.

Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Knopman DS, et al. Neurology. 1999 Mar 10;52(4):714-8. doi: 10.1212/wnl.52.4.714. Neurology. 1999. PMID: 10078715 Clinical Trial.

5

Clinical trials in Alzheimer disease: debate on the use of placebo controls.

Kawas CH, Clark CM, Farlow MR, Knopman DS, Marson D, Morris JC, Thal LJ, Whitehouse PJ. Kawas CH, et al. Among authors: knopman ds. Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):124-9. doi: 10.1097/00002093-199907000-00002. Alzheimer Dis Assoc Disord. 1999. PMID: 10485569 Review.

6

Cerebrospinal fluid beta-amyloid and tau proteins for the diagnosis of Alzheimer disease.

Knopman D. Knopman D. Arch Neurol. 2001 Mar;58(3):349-50. doi: 10.1001/archneur.58.3.349. Arch Neurol. 2001. PMID: 11255435 Review. No abstract available.

7

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Knopman DS, et al. Neurology. 2001 May 8;56(9):1143-53. doi: 10.1212/wnl.56.9.1143. Neurology. 2001. PMID: 11342678

8

A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial.

Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. Quinn J, et al. Among authors: knopman d. Neurology. 2002 Feb 12;58(3):433-7. doi: 10.1212/wnl.58.3.433. Neurology. 2002. PMID: 11839844 Clinical Trial.

9

Survival study of vascular dementia in Rochester, Minnesota.

Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Knopman DS, et al. Arch Neurol. 2003 Jan;60(1):85-90. doi: 10.1001/archneur.60.1.85. Arch Neurol. 2003. PMID: 12533093

10

Mild cognitive impairment in the oldest old.

Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, Ivnik R, Kokmen E, Tangalos E, Edland S, Knopman D, Petersen R. Boeve B, et al. Among authors: knopman d. Neurology. 2003 Feb 11;60(3):477-80. doi: 10.1212/wnl.60.3.477. Neurology. 2003. PMID: 12578930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,294 results

Search Page

Filters